Shire Lobs $30B Unsolicited Offer For Baxalta
Irish drugmaker Shire PLC said Tuesday that it has made an unsolicited stock bid valued around $30 billion to acquire U.S. biotech Baxalta Inc., aiming for a tie-up that would create...To view the full article, register now.
Already a subscriber? Click here to view full article